Celadon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CEL?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	180,738	0.263%
Private Companies	1,233,333	1.79%
Institutions	12,958,430	18.8%
General Public	17,656,057	25.6%
Individual Insiders	36,817,249	53.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.2%.

Top Shareholders

Top 25 shareholders own 73.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
44.4%	James Short	30,572,331	UK£5.4m	0%	no data
6.57%	Paul Allen	4,525,403	UK£791.9k	0%	no data
4.64%	Canaccord Genuity Wealth (International) Ltd.	3,194,923	UK£559.1k	0%	0.01%
2.91%	Global Investment Strategy UK Limited, Asset Management Arm	2,003,371	UK£350.6k	0%	2.48%
1.93%	Jonathan Rickard	1,325,704	UK£232.0k	0%	no data
1.35%	BNY Mellon Advisors, Inc.	932,494	UK£163.2k	0%	no data
1.21%	Charles Stanley & Co. Ltd, Asset Management Arm	829,865	UK£145.2k	0%	no data
1.1%	HSBC Global Asset Management (UK) Limited	757,790	UK£132.6k	0%	no data
0.98%	HBOS Investment Fund Managers Limited	673,934	UK£117.9k	0%	no data
0.95%	IG Group Holdings Plc, Asset Management Arm	655,210	UK£114.7k	0%	0.01%
0.94%	Morgan Stanley, Investment Banking and Brokerage Investments	645,974	UK£113.0k	0%	no data
0.86%	CGF Anton Will Trust Life Interest Fund	591,667	UK£103.5k	0%	no data
0.83%	Jarvis Securities plc, Asset Management Arm	574,143	UK£100.5k	0%	0.01%
0.79%	Evelyn Partners Investment Management LLP	542,580	UK£95.0k	0%	no data
0.68%	Barclays Bank PLC, Wealth and Investment Management Division	469,586	UK£82.2k	0%	no data
0.57%	CGF Anton Discretionary Will Trust	391,666	UK£68.5k	0%	no data
0.49%	Ian Anton	336,236	UK£58.8k	0%	no data
0.47%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	325,000	UK£56.9k	0%	no data
0.45%	Seneca Partners Limited	306,956	UK£53.7k	0%	0.01%
0.29%	Paludum Commercial Corp	200,000	UK£35.0k	0%	no data
0.29%	Cantor Fitzgerald Asset Management	199,910	UK£35.0k	0%	no data
0.28%	SG Hambros Bank Limited, Asset Management Arm	192,256	UK£33.6k	0%	0.01%
0.26%	WH Ireland Group plc	180,738	UK£31.6k	0%	no data
0.16%	Bank Julius Bär & Co Ltd., Asset Management Arm	110,000	UK£19.3k	0%	no data
0.13%	Barratt & Cooke Holdings Limited, Asset Management Arm	89,448	UK£15.7k	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 04:30
End of Day Share Price	2024/12/24 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Celadon Pharmaceuticals Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution